P
Plus Therapeutics D
D
PSTV
0.60310
USD
-0.04
(-6.06%)
مغلق
حجم التداول
5,021
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
10,252,474
الأخبار المقالات
العنوان: Plus Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).